Innovations

 

Acuson Bonsai


Key Features

• Portable, cardiovascular-dedicated ultrasound system

• Design provides flexibility in scanning locations

• User-friendly cardiology applications included

The Acuson Bonsai addresses the increasing demand for quality echo exams by providing a portable and quick system that maintains high-quality imaging and diagnostic confidence through user-friendly applications.

The Acuson Bonsai provides one-touch image optimization, eliminating the need for manual optimization on the part of the sonographer for improved workflow and image quality consistency. The system also comes fully loaded with a complete set of user-friendly cardiology applications for fast and easy handling of routine echo exams. Included applications such as automated ejection fraction and automated intima-media thickness help clinicians acquire measurements in one click, enabling quicker exams and consistent results. The Acuson Bonsai is compatible with a comprehensive set of 14 transthoracic echocardiography and transesophageal echocardiography transducers.

The ergonomic user design of the Acuson Bonsai’s laptop and mobile cart system offers flexibility in scanning locations. The laptop is more than 1.7 cm thinner than the industrial average, and its companion cart has a slim design and small footprint for maneuverability.

The Acuson Bonsai is cleared by the US Food and Drug Administration and available only in the United States.‚Äč

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.